The Valley Desk

Clinical trial reportThe lancet. HIVPublished

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, GSK, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The lancet. HIV
Published
Subject terms
Humans; HIV Infections; Pyridones; Delayed-Action Preparations; Anti-HIV Agents; Treatment Outcome; Drug Therapy, Combination; Viral Load; Injections, Intramuscular; Adolescent; Child; Female
PubMed ID
40049924
PubMed Central ID
PMC12087306
Added to directory
Source checked

Report a correction or request removal